The National Lung Matrix Trial of personalized therapy in lung cancer.

Nature
G MiddletonL J Billingham

Abstract

The majority of targeted therapies for non-small-cell lung cancer (NSCLC) are directed against oncogenic drivers that are more prevalent in patients with light exposure to tobacco smoke1-3. As this group represents around 20% of all patients with lung cancer, the discovery of stratified medicine options for tobacco-associated NSCLC is a high priority. Umbrella trials seek to streamline the investigation of genotype-based treatments by screening tumours for multiple genomic alterations and triaging patients to one of several genotype-matched therapeutic agents. Here we report the current outcomes of 19 drug-biomarker cohorts from the ongoing National Lung Matrix Trial, the largest umbrella trial in NSCLC. We use next-generation sequencing to match patients to appropriate targeted therapies on the basis of their tumour genotype. The Bayesian trial design enables outcome data from open cohorts that are still recruiting to be reported alongside data from closed cohorts. Of the 5,467 patients that were screened, 2,007 were molecularly eligible for entry into the trial, and 302 entered the trial to receive genotype-matched therapy-including 14 that re-registered to the trial for a sequential trial drug. Despite pre-clinical data supp...Continue Reading

References

Jan 21, 2006·Clinical Trials : Journal of the Society for Clinical Trials·Peter F ThallNizar M Tannir
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter Van LooVessela N Kristensen
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Aug 23, 2011·Genome Biology·Jiqiu ChengYves Moreau
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Sep 11, 2012·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jun 22, 2013·Cancer Research·Rachel G LiaoPeter S Hammerman
Sep 28, 2013·Genome Medicine·Reuben J PengellySarah Ennis
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Mar 26, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bristi BasuUdai Banerji
Apr 27, 2016·Nature Reviews. Cancer·T Hedley CarrJ Carl Barrett
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·David G McFaddenHarold Varmus
Apr 27, 2017·The New England Journal of Medicine·Mariam Jamal-HanjaniUNKNOWN TRACERx Consortium
Apr 28, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oliver GautschiAlexander Drilon
Apr 17, 2018·Cancer Discovery·Vivek SubbiahErica K Evans
Jul 18, 2018·Nature Methods·Sangtae KimChristopher T Saunders
Jul 27, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael OffinMatthew D Hellmann
Nov 22, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Roberta CastiglioneAnne Maria Schultheis
Apr 24, 2019·Nature Medicine·Dominic G RothwellMatthew G Krebs
Dec 17, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter SchmidNicholas C Turner

❮ Previous
Next ❯

Citations

Sep 1, 2020·Chembiochem : a European Journal of Chemical Biology·Eugene F Douglass
Jul 17, 2020·Nature·Alexander Drilon, Matthew D Hellmann
Jan 8, 2021·Journal of Clinical Medicine·Fieke E M FroelingDavid K Chang
Oct 31, 2020·The Lancet Oncology·Martin Schuler
Dec 18, 2020·Frontiers in Cell and Developmental Biology·Maria M HaykalOcéane C B Martin
Nov 24, 2020·Clinical Oncology : a Journal of the Royal College of Radiologists·D Dodwell, R Shakir
Mar 1, 2021·Current Treatment Options in Oncology·David Gómez-PeregrinaCésar Serrano
Mar 13, 2021·Oncogene·Yuanwang PanKwok-Kin Wong
Mar 26, 2021·Nature Reviews. Clinical Oncology·Abhijit PalJohann de Bono
Apr 24, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·John A HickmanLisa Hutchinson
Jan 14, 2021·Inflammatory Bowel Diseases·Claudio Fiocchi, Dimitrios Iliopoulos
May 28, 2021·British Journal of Cancer·Allan Michael Jordan
May 1, 2021·Current Opinion in Pulmonary Medicine·Francesco Passiglia, Giorgio V Scagliotti
Aug 7, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Barbara MeloskyQuincy Chu
Aug 7, 2021·Cell·Shankha SatpathyUNKNOWN Clinical Proteomic Tumor Analysis Consortium
Aug 14, 2021·Nature Medicine·Meina WangChris Boshoff
Aug 15, 2021·Clinical Radiology·M K ThompsonJ D Brenton
Aug 22, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Colin R LindsayJulien Mazières
Aug 26, 2021·Pharmacogenomics and Personalized Medicine·Alice MogenetPascale Tomasini
Sep 10, 2021·Nature·Robert BenthamNicholas McGranahan
Aug 29, 2020·Cancer Cell·Siddhartha DevarakondaDaniel Morgensztern
Sep 19, 2021·Cell Death and Differentiation·Antonella MontinaroHenning Walczak
Sep 24, 2021·Science·Toshikazu UshijimaPatrick Tan
Oct 1, 2021·British Journal of Cancer·Elisabet AliagasErnest Nadal

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
biopsy
biopsies
Rapid

Clinical Trials Mentioned

ISRCTN38344105
NCT02664935

Software Mentioned

RECIST
Strelka
PennCNV
Excel
CRAFT
illumina DesignStudio
Illumina BaseSpace
Manta
ASCAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Adam FalconiJayson L Parker
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Daniel MorgenszternRamaswamy Govindan
© 2021 Meta ULC. All rights reserved